THOUSAND OAKS, Calif.,
Nov. 25, 2020 /PRNewswire/ -- Amgen
(NASDAQ:AMGN) will present at the Evercore ISI Virtual HealthCONx
Conference at 1:50 p.m. ET on
Tuesday, Dec. 1, 2020. David M.
Reese, M.D., executive vice president of Research and
Development and Peter H. Griffith,
executive vice president and chief financial officer at Amgen will
present at the conference. Live audio of the presentation can be
accessed from the Events Calendar on Amgen's website,
www.amgen.com, under Investors. A replay of the webcast will also
be available on Amgen's website for at least 90 days following the
event.
About Amgen
Amgen is committed to unlocking the
potential of biology for patients suffering from serious illnesses
by discovering, developing, manufacturing and delivering innovative
human therapeutics. This approach begins by using tools like
advanced human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages
its expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer
since 1980, Amgen has grown to be one of the
world's leading independent biotechnology companies, has
reached millions of patients around the world and is developing a
pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow
us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand Oaks
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631
(media)
Arvind Sood, 805-447-1060
(investors)
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-evercore-isi-virtual-healthconx-conference-301180785.html
SOURCE Amgen